(PharmaNewsWire.Com, October 18, 2017 ) The global Diabetic Retinopathy Market is projected to be around $2.6 billion by 2025. This growth can be attributed to increase in prevalence of diabetes, increase in demand for early screening techniques and increase awareness about disease and available treatments among patients. Increasing incidence of diabetes caused blindness will further enhance the growth of market during forecast period. As per International Diabetes Federation (IDF) 415 million people worldwide suffered from diabetes and diabetes related complications as of 2015 and this number is expected to reach 642 million by 2040. Diabetic retinopathy is characterized by neovascularization of retina, blurred vision and moderate to severe eye pain. This further leads to retinal detachment and complete loss of vision. Such high complications will lead to increase in demand for methods to treat diabetes retinopathy which will drive the market during forecast period However, dearth of skilled professionals and poor insurance facilities are restraining the market growth. Major Key Player Bayer Healthcare Novartis AG Actavis PLC ThromboGenics irnaomics Incorporation Genentech Glycadia Pharmaceuticals Regeneron Pharmaceuticals Inc. Alimera Sciences Ampio Pharmaceuticals.
Get complete access to Reports: http://www.crystalmarketresearch.com/report/diabetic-retinopathy-market DDiabetic Retinopathy Market is segmented as follows – By Type: • Proliferative Diabetic Retinopathy • Diabetic Macular Edema By Management: • Anti VEGF Drugs • Steroid Implants • Laser Surgeries • Vitrectomy By Region: • North America o U.S o Canada o Mexico • Europe o Germany o France o UK o Italy o Spain o Rest of Europe • Asia-Pacific o Japan o China o Australia o India o South Korea o Rest of Asia-Pacific • Rest of the World o Brazil o South Africa o Saudi Arabia o Turkey o United Arab Emirates
Get Sample of this Report @ http://www.crystalmarketresearch.com/report-sample/HC0622 Table of Contents 1. Introduction 2. Executive Summary 3. Market Overview 3.1. Introduction 3.1.1. Market Definition 3.1.2. Market Segmentation 3.2. Market Share Analysis 3.3. Market Dynamics 3.3.1. Drivers 3.3.1.1. High Prevalence of Diabetes 3.3.1.2. Rise in Demand for Early Detection Techniques 3.3.1.3. Increased Awareness about Diabetes 3.3.2. Restraints 3.3.2.1. Dearth of Skilled Professionals 3.3.2.2. Poor Insurance Facilities 3.3.3. Opportunities 3.3.3.1. Emerging Market to Offer Lucrative Growth Opportunities 3.4. Industry Trends 4. Diabetic Retinopathy Market, By Product 5. Diabetic Retinopathy Market, By Application 6. Diabetic Retinopathy Market, By Region 7. Company Profiles
Buy Report @ http://www.crystalmarketresearch.com/checkout/22 About Us: Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy. Contact Us: Judy 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: +1-888-213-4282 Email: sales@crystalmarketresearch.com Blog: blog.crystalmarketresearch.com Website: www.crystalmarketresearch.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
